Decentralization, AI, and Gene Editing are Opportunities for CGT Contractors

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 28 Oct, 16:00 UTC

CDMOs already play a critical role in the cell and gene therapy development and manufacturing space and, says Rose Biosolutions, with emerging bioprocessing technologies, production methods, and strategies, are creating even more opportunities for contractors. The post Decentralization, AI, and…